Founders Capital Management (Texas)’s Ocular Therapeutix OCUL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$18.6K Hold
2025
Q1
$14.7K Hold
2024
Q4
$17.1K Hold
2024
Q3
$17.4K Hold
2024
Q2
$13.7K Hold
2024
Q1
$18.2K Hold
2023
Q4
$8.92K Sell
2023
Q3
$11K Hold
2023
Q2
$18.1K Hold
2023
Q1
$18K Buy
2022
Q4
$7K Hold
2022
Q3
$10K Hold
2022
Q2
$10K Buy